ATNM Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ATNM shares is 108, representing 27.41% of the company's common stock.

UBS GROUP AG, in the last quarter, reduced its stake in ATNM by -44.12% restricting it's holding to 73.11 thousand shares of worth nearly $26.00K. N/A also lessened N/A of the ATNM shares from its portfolio, reducing its holding to N/A shares of worth N/A. N/A also shunned ATNM shares holding by N/A last quarter which brought its holding to N/A shares worth N/A.

As per its latest 13F filing, TCI WEALTH ADVISORS, INC. increased its stake in ATNM by 100% in the last quarter. The institutional holder raised its holding to 3 thousand shares having worth more than $1.00K. VALLEY NATIONAL ADVISERS INC also added 100% more shares of ATNM to its portfolio, raising its holding to 2 thousand shares of worth $1.00K. TRUST CO OF VERMONT also increased its ATNM shares holding by 100% which brought its holding to 1.5 thousand shares worth $1.00K.

The insider with the most stakes in ATNM is Memorial Sloan-Kettering Cancer Center , 10 percent owner at the company. Additionally, ATNM stock is highly held by Chairman & CEO SETH SANDESH and Principal Financial Officer O'Loughlin Steve among others.

Company executives, directors, and other insiders own 2.04% percent of Actinium Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ATNM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include MEMORIAL SLOAN-KETTERING CANCER CENTER.

There have been 0 transaction(s) during the past 6-months in which Actinium Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 0 Actinium Pharmaceuticals, Inc. shares are held by insiders, which represents about 2.04% of ATNM stock.

ATNM 10 percent owner, Memorial Sloan-Kettering Cancer Center holds the largest portfolio of the company's shares. ATNM shares owned by Memorial total nearly 4.71 million.

TCI WEALTH ADVISORS, INC. is the largest institutional owner in ATNM which holds 3 thousand shares worth $1.00K or 0% of the total ATNM shares outstanding followed by VALLEY NATIONAL ADVISERS INC with ownership of 2 thousand shares representing 0% of the ATNM ownership. TRUST CO OF VERMONT is the third largest stakeholder with 1.5 thousand shares or 0% of the ownership worth more than $1.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ATNM is concerned, it is a stock which is optionable.

Number of ATNM shares short is 2.13M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 31.15M shares of ATNM are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ATNM has 30.37M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ATNM is 1.38.